Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07121205) titled 'High-Dose Dual Therapy for H. Pylori Eradication (RETRO-HP Study)' on Aug. 4.

Study Type: Observational

Primary Sponsor: Liyueyue

Condition: HELICOBACTER PYLORI INFECTIONS

Intervention: Other: This study is a retrospective study, and all data have been collected in advance with no active intervention required.

Recruitment Status: Not recruiting

Date of First Enrollment: June 1, 2025

Target Sample Size: 1600

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07121205

Published by HT Digital Content Services with permission from Health Daily Digest....